Human leukocyte antigen (HLA) class I/II expression as a predictive biomarker for response to immune oncology (IO) therapy in metastatic clear-cell renal cell carcinoma (m-ccRCC) - Vigipallia

0 avis

Human leukocyte antigen (HLA) class I/II expression as a predictive biomarker for response to immune oncology (IO) therapy in metastatic clear-cell renal cell carcinoma (m-ccRCC)

Archive ouverte

Kinget, L. | Roussel, E. | Lambrechts, D. | Boeckx, B. | Verbiest, A. T. L. | Zucman-Rossi, Jessica | Couchy, G. | Dalban, C. | Meylan, M. | Chabaud, S. | Vano, Y. | Sautes-Fridman, C. | Fridman, W-H. | Baldewijns, M. | Albersen, M. | Rioux-Leclercq, N. | Tantot, F. | Chaput, N. | Beuselinck, B. | Albiges, L.

Edité par CCSD ; Elsevier -

International audience

Langue: en

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

Kidney ccRCC immune classification (KIC) enhances the predictive value of T effector (Teff) and angiogenesis (Angio) signatures in response to nivolumab (N)

Archive ouverte | Meylan, M. | CCSD

International audience

NIVOREN GETUG-AFU 26 translational study: Baseline peripheral cytokines predict survival in metastatic clear cell renal carcinoma (RCC) treated with nivolumab

Archive ouverte | Ajuria, L. Carril | CCSD

International audience

Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy

Archive ouverte | White, K. | CCSD

International audience

Chargement des enrichissements...